RxCap

Overview
News
Hospital-at-Home?
Product stageSegments
Expansion
?
Home Care Workflow
?

RxCap, Inc. is a Boston-based prescription adherence technology corporation that provides a modular suite of enablement software, APIs, and prescription adherence devices to support healthcare enterprises in developing customized remote therapeutic monitoring programs. The company's solutions utilize connected prescription vial closure devices and complementary cloud-based software to monitor patients' medication adherence.

RxCap's technology works by using a cellular signal to report to the cloud-based software platform when the prescription vial has been opened, allowing healthcare providers to assess whether the medication has been taken as prescribed. The solutions require no additional effort from the patient and can be easily integrated with existing enterprise workflows to manage patient needs effectively.

A key differentiator for RxCap is its ability to enable healthcare enterprises to quickly build revenue-generating remote patient monitoring (RPM) programs that integrate with their existing care workflows, leading to improved patient outcomes and reduced healthcare costs. In April 2024, the company partnered with Gerresheimer, a global provider of pharmaceutical containment solutions, to offer connected adherence solutions through Gerresheimer's subsidiary Centor, the US market leader in prescription vials.

Key customers and partnerships

In September 2022, RxCap partnered with ZEPHYRx, a remote respiratory monitoring solutions provider, to integrate ZEPHYRx's cloud spirometry platform with RxCap's remote monitoring platform. This partnership enabled RxCap's enterprise customers, such as providers and payers, to monitor the lung function of patients with serious pulmonary conditions.

In March 2022, RxCap announced a partnership with Medistics, a New Jersey-based care management company, to launch a turnkey solution for CMS RPM and RTM (Remote Therapeutic Monitoring) programs. This joint offering focused on enabling qualified healthcare professionals to offer reimbursable RPM and RTM services to provide more personalized and proactive care for their patients.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Boston MA USA
Founded year:
2019
Employees:
1-10
IPO status:
Private
Total funding:
USD 19.7 mn
Last Funding:
USD 19.7 mn (Series Unknown; May 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.